Lakes > Public Hospital Services > Te Whatu Ora – Health New Zealand Lakes >
Oncology | Lakes | Te Whatu Ora
Public Service, Oncology, Haematology
Medical Oncology Clinical Trials - Breast: PantoCIN
Breast: PantoCIN
Pantoprazole Prophylaxis Against Delayed Chemotherapy-Induced Nausea and Vomiting (CINV) for Patients Receiving Breast Cancer Chemotherapy
This study is currently recruiting participants.
Primary Objective: This phase II, randomised double-blind, placebo controlled, crossover study explores whether a commonly used medication called Pantoprazole can help prevent delayed nausea and vomiting from chemotherapy for early breast cancer. Delayed nausea, and occasionally vomiting, can occur after breast cancer chemotherapy, affecting quality of life. A potential cause of these delayed side effects is that the chemotherapy may cause stomach irritation. Pantoprazole is commonly used to treat stomach irritation by reducing stomach acid, which may in turn improve nausea and/or vomiting.
Principal Investigator: Prashanth Hari Dass
Research Coordinators: Karen and Paula
Trial Website: https://clinicaltrials.gov/ct2/show/NCT03948477